2020 American Transplant Congress » Poster Session B: Lung: All Topics

3:30pm-4:00pm

A Large Animal Model of Ex-Vivo Lung Perfusion as a Platform to Deliver Therapeutic Agents to Lungs Before Lung Transplant

T. M. Egan¹, B. Haithcock¹, M. H. Ali¹, J. W. Blackwell¹, B. Masuodi¹, S. Shipley², T. Long³, A. Akerman¹, S. Montgomery⁴, H. Yuan⁵, P. Stewart⁶, J. Potenziano⁷, C. Sekaran⁷, R. Fitch⁷

3:30pm-4:00pm

Acute Kidney Injury And Chronic Kidney Disease After Lung Transplantation: Incidence And Risk Factors In A Large Single-center Cohort

D. Abdelwahab, R. Marron, Z. Choudhry, I. Lee, J. Wu, J. Brown

3:30pm-4:00pm

Alternate Triazole Therapy for Breakthrough Invasive Fungal Disease in Lung Transplant Recipients on Triazole Prophylaxis

A. Abbas, H. Hassouna, F. Marco Canosa, K. D. Brizendine

3:30pm-4:00pm

Amiodarone Use in Lung Transplant Recipients with New Onset Atrial Arrhythmias

E. Klipsch¹, R. Rachwan², I. KutKut³, D. Roe², C. Hage², T. Hathaway¹, R. S. Mangus²

3:30pm-4:00pm

Association between Pre-Transplant Frailty and Increased Length of Stay after Lung Transplantation

J. Schaenman, N. Ventigan, J. Huang, S. Jaladanki, L. Shih, S. Gee, D. Sayah, S. S. Weigt, A. Ardehali, R. Biniwale, D. Goldwater

3:30pm-4:00pm

Donor Lung Travel Distance and Time

C. Lehr¹, M. Skeans², M. Valapour¹, E. Lease³

3:30pm-4:00pm

Effects of Alpha-1 Proteinase Replacement Continuation Post-Lung Transplantation in Alpha-1 Antitrypsin Deficiency: A Single Center Case Series

M. Bremer, A. Feist, M. Mariski, G. Yung, T. Floreth, E. Schonhoft, G. Schooler, E. Golts, K. Afshar

3:30pm-4:00pm

Epidemiology of Invasive Candidiasis in Lung Transplant Recipients at a Large Transplant Center

F. J. Marco Canosa¹, J. A. Morillas¹, H. Hassouna², K. Brizendine¹

3:30pm-4:00pm

Epidemiology of Non-Aspergillus Mold in Lung Transplant Recipients at a Large Transplant Center

J. A. Morillas¹, F. J. Marco Canosa¹, H. Hassouna², K. Brizendine¹

3:30pm-4:00pm

Evaluation of SUBA-Itraconazole Use in Lung Transplant Recipients

J. G. Youssef¹, C. Ahmed¹, B. J. Pierce², C. Pham², F. Ye¹, K. Tatum¹, S. Yau¹, A. Goodarzi¹, H. J. Huang¹

3:30pm-4:00pm

Evaluation of the Mitra Microsampling Device for TTV Measurement in Human Whole Blood of Lung Transplant Recipients

J. Mühlbacher¹, B. Lickefett¹, K. Doberer², B. Reiter³, S. Aberle⁴, G. Bond², P. Jaksch¹

3:30pm-4:00pm

Granulocyte Colony Stimulating Factor: Trigger of Rejection in Lung Transplantation?

K. Walter¹, M. Patti¹, S. Khalid², L. Kemp¹, L. J. Lobo³, R. Coakley³, S. Krishnan³, C. T. Doligalski¹

3:30pm-4:00pm

Green Channel of Human Organ Transport (GCHOT) Improved the Utilization Rate of Chinese Citizens’ Donated Lungs: A Single-Center Data Analysis

J. Chen, X. Li, C. Hu, F. Liu

3:30pm-4:00pm

Impact of Donor Lung Pathogenic Bacteria Detected by Next-Generation Sequencing on Early Post-Transplant Outcomes in Lung Transplant Recipients

D. Liu, J. Zhang, J. Chen

3:30pm-4:00pm

Impact of the 2015 LAS Revisions on Lung Candidates with Pulmonary Vascular Disease

K. Lindblad¹, R. Goff¹, K. Chan²

3:30pm-4:00pm

Is Total Ischemic Time a Measure of OPTN Efficiency? Monitoring the Impact of Lung Allocation Policy on Ischemic Time

A. M. Placona¹, R. R. Goff¹, P. Shay², B. Carrico¹

3:30pm-4:00pm

Late Onset Primary Graft Dysfunction after Lung Transplantation Correlates with Transplant Arteriosclerosis in a Humanized Mouse Model

M. Franz¹, T. Siemeni¹, A. Knöfel¹, W. Sommer¹, M. Avsar¹, F. Ius¹, I. Tudorache¹, C. Kühn¹, C. S. Falk², G. Warnecke¹, A. Haverich¹

3:30pm-4:00pm

Lung Mucosal Biopsies Deteriorate with Time Post-Transplant: A Molecular Analysis

M. D. Parkes¹, P. Halloran¹, K. Halloran², &. the INTERLUNG Study Group³

3:30pm-4:00pm

Monitoring the Removal of Donation Service Area from Lung Allocation

R. R. Goff¹, R. Daly², E. D. Lease³

3:30pm-4:00pm

Oral versus Intravenous Mycophenolate Mofetil Administration: A Single Center Experience on Incidence of Acute Kidney Injury

P. Chung¹, K. Forrester², S. Ganesh¹

3:30pm-4:00pm

Outpatient Treatment of Paramyxovirus with Oral Ribavirin is Safe and Effective in Lung Transplant Recipients

A. W. Rogers¹, B. J. Pierce¹, C. Pham¹, J. T. Swan¹, H. J. Huang²

3:30pm-4:00pm

Survival Following Simultaneous Liver-Lung versus Liver Alone Transplantation: Results of the US National Experience

J. Purvis, M. C. Mcleod, B. J. Orandi, D. E. Eckhoff, J. E. Locke, R. M. Cannon

3:30pm-4:00pm

The Negative Impact of Inherent Oxidative Stress in Marginal Lungs on Ex Vivo Lung Perfusion

K. Noda¹, B. J. Philips¹, M. Velayutham², T. Harano¹, P. Reck dos Santos¹, S. Shiva², P. G. Sanchez¹

3:30pm-4:00pm

The Safety and Effectiveness and of Isoniazid Empirical Prophylaxis Compared to Screening Based Prophylaxis Post Lung Transplantation

G. B. Korayem¹, R. S. Almaghrabi², N. I. AlSuhaibani¹, G. S. AlSwailem¹, M. A. AlShammari¹, D. A. Aleissa³

3:30pm-4:00pm

Transpulmonary Gradient as a Predictor for Outcomes after Single Lung Transplantation in Patients with Pulmonary Hypertension

A. Madde¹, E. Chan², J. Ryan², P. Reck Dos Santos², M. Morrell³, J. Luketich², P. Sanchez²

3:30pm-4:00pm

Voriconazole Associated Adverse Drug Events and Drug Monitoring in Lung Transplant Recipients

C. Y. Luo¹, R. G. Nador², R. D. Levy², J. Yee², L. Wei², N. Partovi¹